Rising demand for personalized medicines is a key factor driving the global transcriptomics market, says Fortune Business Insights in a report, titled “Transcriptomics Market Size, Share and Global Trend By Technology (Polymerase Chain Reaction (PCR), Microarray, Next-Generation Sequencing (NGS)), By Application (Drug Discovery, Clinical Diagnostics, Toxicogenomics), By End-User (Academic and Research Institutes, Pharmaceutical Companies, Biotechnology Companies) and Geography Forecast till 2026.” Rapid innovations and improvements in healthcare infrastructure is expected to aid the growth of the global transcriptomics market.
Key players leading the global Transcriptomics Market include:
- Thermo Fisher Scientific
- Agilent Technologies
- GE Healthcare
- Bio-Rad Laboratories
- Fluidigm Corporation
- Promega Corporation
Browse Complete Report:
According to the report, the increasing demand for transcriptomics due to its DNA microarrays and next-generation sequencing technologies has impelled new companies to enter the market. This factor will encourage the growth of the global transcriptomics market. For instance, in April 2017, Seven Bridges, a biomedical data analysis company announced a financial investment in Spatial Transcriptomics AB, a life science start-up, which is developing innovative technology to analyze tissue samples in two dimensions.
The report provides a comprehensive overview of the transcriptomics industry. It offers insights into factors enablibg growth in the global transcriptomics market. The study focuses on the recent product launches and acquisitions by leading market players.
Increasing R&D Investments Will Propel Growth
The rapid adoption of transcriptomics and increasing demand for personalized medicine is expected to boost the global transcriptomics market revenue during the forecast period. Further, the launch of MI Transcriptome, an advanced gene profiling product is expected to stimulate the growth of the global transcriptomics market. For instance, Caris Life Sciences launched an advanced gene profiling product, MI Transcriptome which enables Whole Transcriptome Sequencing (WTS). The newly developed technology has the capability to provide in detail RNA sequencing analysis. In addition, growing number of biopharmaceutical companies and rising expenditure on research and development is predicted to further enable the growth of the global transcriptomics market.
Get Sample PDF:
Launch Of CORALL Will Favor Growth
Lexogen, a transcriptomics company focused on the development of innovative kits and software for RNA-Seq, launched CORALL-Total RNA-Seq Library Prep Kit. The new kit will be utilized in transcriptome analysis. Moreover,the acquisition of Spatial Transcriptomics by 10x Genomics is expected to uplift the global transcriptomics market shares during the forecast period. For instance, 10x Genomics acquired Spatial Transcriptomics, a potential player in spatial genomics. Nonetheless, lack of skilled professionals in emerging nations is likely to restrict the global transcriptomics market growth during the forecast period.
Rising Prevalence Of Chronic Disorders Will Enable Growth In North America
Geographically, the global transcriptomics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global transcriptomics market owing to the rising demand for personalized medicines and growing cases of chronic disorders such as cancer and others. In addition, rising investment in the research and development of transcriptomics technologies will further accelerate growth in North America. Asia Pacific is expected to grow at a significant CAGR during the forecast period due to the increasing number of pharmaceutical and biotechnology companies in the region. Moreover, high demand for transcriptomics technologies and increasing investments in R&D and drug development will further boost growth in Asia Pacific.
Speak to Analyst:
View Related Reports: